Opaleye Management Inc. Catalyst Biosciences, Inc. Transaction History

Opaleye Management Inc.

  • $411 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$4.1 - $5.33 $5.13 Million - $6.66 Million
-1,250,000 Closed
0 $0
Q1 2021

May 18, 2021
BUY
$4.93 - $7.15 $5.43 Million - $7.87 Million
1,101,200 Added 740.05%
1,250,000 $6.3 Million
Q4 2020

Feb 12, 2021
BUY
$4.55 - $7.29 $677,040 - $1.08 Million
148,800 New
148,800 $939,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email